Allianz Asset Management
ANTH

Allianz Asset Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Allianz Asset Management’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-19,425
Closed -$490K – 2730
2016
Q3 		$490K Sell
19,425
-3,602
-16% -$90.8K ﹤0.01% 2362
2016
Q2 		$569K Buy
23,027
+3,575
+18% +$101K ﹤0.01% 2283
2016
Q1 		$563K Sell
19,452
-1,100
-5% -$29.8K ﹤0.01% 2235
2015
Q4 		$763K Sell
20,552
-2,143
-9% -$94.6K ﹤0.01% 2076
2015
Q3 		$1.11M Buy
+22,695
New +$1.59M ﹤0.01% 1791

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Allianz Asset Management's ANTH Position: Q4 2016 in Review

Allianz Asset Management sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q4 2016, closing a stake of 19,425 shares — an estimated $490K sold.

Allianz Asset Management first reported a position in ANTH in Q3 2015 and held it in 5 quarters. The position peaked at $1.11M in Q3 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

  • Allianz Asset Management reported no remaining Anthera Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Allianz Asset Management sold 19,425 Anthera Pharmaceuticals, Inc. shares in Q4 2016, an estimated $490K.
  • Allianz Asset Management first reported a position in Anthera Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
  • Allianz Asset Management's Anthera Pharmaceuticals, Inc. position peaked at $1.11M in Q3 2015.
  • 72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on Allianz Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.